Atrial Sensing Capability for Better Detection of Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 640 participants.

Also called NCT03932604

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 640 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03932604
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03932604. Randomized; no masking; primary purpose screening. Start 2019-06-01 (actual); primary completion 2021-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atrial Sensing Capability for Better Detection of Atrial Fibrillation
Condition
Implantable Cardioverter Defibrillator
Condition
Cardiac Event
Condition
Cardiac Arrhythmia
Intervention (Device)
Atrial sensing On mode
Lead sponsor
Samsung Medical Center (class: other)
Collaborator
Biotronik SE & Co. KG (class: industry)

Record details

Record id
cardio:ct-nct03932604
Content hash
efc04e168ed82a05526183ab4d8e1b553a9085a9bb907c0380553a9cb46b7514